Literature DB >> 15039092

Identification of genomic groups in the genus Stenotrophomonas using gyrB RFLP analysis.

Tom Coenye1, Elke Vanlaere, John J LiPuma, Peter Vandamme.   

Abstract

Stenotrophomonas maltophilia isolates have been recovered from various clinical samples, including the respiratory tract of cystic fibrosis (CF) patients, but this organism is also widespread in nature. Previously it has been shown that there is a considerable genomic diversity within S. maltophilia. The aims of our study were to determine the taxonomic resolution of restriction fragment length polymorphism (RFLP) analysis of the polymerase chain reaction-amplified gyrB gene for the genus Stenotrophomonas. Subsequently, we wanted to use this technique to screen a set of S. maltophilia isolates (with emphasis on a specific subset, isolates recovered from CF patients), to assess the genomic diversity within this group. In this study we investigated 191 Stenotrophomonas sp. isolates (including 40 isolates recovered from CF patients) by means of gyrB RFLP. The taxonomic resolution of gyrB RFLP, and hence its potential as an identification tool, was confirmed by comparison with results from published and novel DNA-DNA hybridisation experiments. Our data also indicate that the majority of CF isolates grouped in two clusters. This may indicate that isolates from specific genomic groups have an increased potential for colonisation of the respiratory tract of CF patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15039092     DOI: 10.1016/S0928-8244(03)00307-9

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  9 in total

1.  Correct implementation of matrix-assisted laser desorption ionization-time of flight mass spectrometry in routine clinical microbiology.

Authors:  Annelies De Bel; Ingrid Wybo; Denis Piérard; Sabine Lauwers
Journal:  J Clin Microbiol       Date:  2010-05       Impact factor: 5.948

2.  Cold-adapted microorganisms as a source of new antimicrobials.

Authors:  Leandro A Sánchez; Fiorella F Gómez; Osvaldo D Delgado
Journal:  Extremophiles       Date:  2008-11-18       Impact factor: 2.395

3.  Detection of Bacillus and Stenotrophomonas species growing in an organic acid and endocrine-disrupting chemical-rich environment of distillery spent wash and its phytotoxicity.

Authors:  Ram Chandra; Vineet Kumar
Journal:  Environ Monit Assess       Date:  2016-12-20       Impact factor: 2.513

Review 4.  Stenotrophomonas maltophilia: an emerging global opportunistic pathogen.

Authors:  Joanna S Brooke
Journal:  Clin Microbiol Rev       Date:  2012-01       Impact factor: 26.132

5.  Are animals a source of Stenotrophomonas maltophilia in human infections? Contributions of a nationwide molecular study.

Authors:  Aurélie Jayol; Camille Corlouer; Marisa Haenni; Mélanie Darty; Karine Maillard; Marine Desroches; Brigitte Lamy; Estelle Jumas-Bilak; Jean-Yves Madec; Jean-Winoc Decousser
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-02-27       Impact factor: 3.267

6.  A Stenotrophomonas maltophilia multilocus sequence typing scheme for inferring population structure.

Authors:  Sabine Kaiser; Klaus Biehler; Daniel Jonas
Journal:  J Bacteriol       Date:  2009-02-27       Impact factor: 3.490

7.  Genotyping of environmental and clinical Stenotrophomonas maltophilia isolates and their pathogenic potential.

Authors:  Martina Adamek; Jörg Overhage; Stephan Bathe; Josef Winter; Reinhard Fischer; Thomas Schwartz
Journal:  PLoS One       Date:  2011-11-15       Impact factor: 3.240

8.  Identification of pathogenic Leptospira species by conventional or real-time PCR and sequencing of the DNA gyrase subunit B encoding gene.

Authors:  Andrew T Slack; Meegan L Symonds; Michael F Dohnt; Lee D Smythe
Journal:  BMC Microbiol       Date:  2006-10-27       Impact factor: 3.605

9.  PCR-based rapid genotyping of Stenotrophomonas maltophilia isolates.

Authors:  Emanuela Roscetto; Francesco Rocco; M Stella Carlomagno; Mariassunta Casalino; Bianca Colonna; Raffaele Zarrilli; Pier Paolo Di Nocera
Journal:  BMC Microbiol       Date:  2008-11-24       Impact factor: 3.605

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.